Shattuck Labs, Inc.
Heterodimeric proteins for modulating gamma delta T cells
Last updated:
Abstract:
The present technology relates, inter alia, to compositions and methods, including heterodimeric proteins that find use in the treatment of disease, such as immunotherapies for cancer and autoimmunity.
Status:
Grant
Type:
Utility
Filling date:
3 Jun 2020
Issue date:
27 Apr 2021